ACTRN12612000010897已完成4 期
A randomised, double blind trial of Azithromycin versus Amoxycillin-Clavulate to treat mild to moderate respiratory exacerbations in children with non-Cystic Fibrosis bronchiectasis, Study Two.
Qld Children's Medical Research Institute0 个研究点目标入组 170 人开始时间: 2012年1月4日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 170
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- o limit 至 19 Years(—)
- 性别
- All
入选标准
- •Aged less than 18 years.
- •Bronchiectasis, as defined by HRCT scan within the last 5-years OR followed by a respiratory physician for treatment of bronchiectasis if diagnosed earlier.
- •2 or more respiratory exacerbations of bronchiectasis symptoms in the last 18 months prior to study enrolment.
排除标准
- •Cystic Fibrosis (sweat chloride >35mmol/L or gene mutation). Liver dysfunction. Severe (hypoxic, dyspnoea or hospitalisation required) or recent exacerbation (in the last 4 weeks prior to study enrollment. Known hypersensitivity to macrolides or penicillins. Taking regular maintenance antibiotics of the same class as the investigational antibiotics (macrolides and penicillins), or has taken macrolides or penicillins within 3 weeks of study enrolment. Current or recent (within 4 months prior to study enrolment) identification of pseudomonas organism in the airways. Current treatment for an oncology condition of any kind.
研究者
相似试验
已完成
不适用
A comparison of azithromycin and ofloxacin in the treatment of typhoid in adult patients in LaosInfections and InfestationsTyphoid feverISRCTN66534807niversity of Oxford (UK)88
进行中(未招募)
不适用
An open-label, multi-center trial of azithromycin pharmacokinetics in sinus aspirate and serum following oral administration of either a 500 mg immediate-release (IR) once-daily 3 day regimen or a single-dose 2.0g azithromycin microspheres regimen in subjects with acute bacterial sinusitis.Acute bacterial sinusitisMedDRA version: 7.1Level: LLTClassification code 10060841EUCTR2005-000639-13-SEPfizer Ltd30
已完成
不适用
Antibiotics to prevent preterm birthISRCTN84023116niversity of Liverpool (UK)2,300
Unknown
4 期
Azithromycin in Hospitalized COVID-19 PatientsCOVID-19NCT04359316Shahid Beheshti University of Medical Sciences40
已完成
Unknown
Prospective observational study of azithromycin in patients with acute exacerbation of fibrosing interstitial pneumoniaacute exacerbation of fibrosing interstitial pneumoniaJPRN-jRCT1090220095Dividion of respiratory medicine, Saiseikai Kumamoto Hospital30
